跳至主要内容
临床试验/JPRN-UMIN000006994
JPRN-UMIN000006994已完成2 期

Phase II trial of neoadjuvant chemotherapy for unresectable liver metastasis of colorectal cancer - TAMA conversion trial (TAC trial)

Surgery, Kyorin university hospital0 个研究点目标入组 10 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

This clinical trial was discontinued due to a lack of case accumulation.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with previous histories of severe drug hypersensitivity or drug allergies 2) Patients with multiple primaries 3) Patients with metastasis outside the liver and regional lymph nodes 4) Patients with infection (fever of 38 degrees C or over) 5) Patients with severe comobidities (interstitial pneumonia or pulmonary fibrosis, cardiac failure, renal failure, liver failure, uncontrollable diabetes or hypertension, jaundice) 6) Patients with pleural effusion or ascites requiring treatment 7) Patients with diarrhea (watery) 8) Patients receiving atazanavir sulfate or flucytosine treatment 9) Pregnant women and women suspected of being pregnant and lactating women 10) Patients evaluated as unsuitable for this trial by the doctor in charge 11) Patients with arterial or venous thrombosis in KRAS mutant cases

研究者

发起方
Surgery, Kyorin university hospital

相似试验